These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7706525)

  • 1. Limited discriminant value of lipoprotein AI, lipoprotein Lp(a) and other lipoprotein particles in patients with and without early onset ischaemic heart disease.
    Vallance DT; Staunton HA; Winder AF
    J Clin Pathol; 1995 Jan; 48(1):70-4. PubMed ID: 7706525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly study.
    Sweetnam PM; Bolton CH; Downs LG; Durrington PN; MacKness MI; Elwood PC; Yarnell JW
    Eur J Clin Invest; 2000 Nov; 30(11):947-56. PubMed ID: 11114956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.
    Wilund KR; Colvin PL; Phares D; Goldberg AP; Hagberg JM
    Metabolism; 2002 Aug; 51(8):1053-60. PubMed ID: 12145781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) is a potential coronary risk factor.
    Fujino A; Watanabe T; Kunii H; Yamaguchi N; Yoshinari K; Watanabe Y; Mutou M; Ishikawa S; Ogyuu A; Ashikawa K; Maruyama Y
    Jpn Circ J; 2000 Jan; 64(1):51-6. PubMed ID: 10651207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects.
    Tilly-Kiesi M; Lichtenstein AH; Joven J; Vilella E; Cheung MC; Carrasco WV; Ordovas JM; Dolnikowski G; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3513-8. PubMed ID: 9437200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentration.
    Bigot E; Robert B; Bard JM; Mainard F
    Clin Chim Acta; 1997 Sep; 265(1):99-111. PubMed ID: 9352133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of lipoprotein particles LpAI and LpAI:AII in patients before coronary bypass surgery.
    Coste-Burel M; Mainard F; Chivot L; Auget JL; Madec Y
    Clin Chem; 1990 Nov; 36(11):1889-91. PubMed ID: 2242564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.
    Oyelola OO; Ajayi AA; Babalola RO; Stein EA
    J Natl Med Assoc; 1995 Feb; 87(2):113-8. PubMed ID: 7897682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
    Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
    Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoproteins and lipoprotein particles in Moroccan patients with previous myocardial infarction.
    Adlouni A; el Messal M; Ghalim N; Saïle R
    Int J Clin Lab Res; 1997; 27(4):247-52. PubMed ID: 9506269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.
    Cantin B; Gagnon F; Moorjani S; Després JP; Lamarche B; Lupien PJ; Dagenais GR
    J Am Coll Cardiol; 1998 Mar; 31(3):519-25. PubMed ID: 9502629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study).
    Luc G; Bard JM; Evans A; Arveiler D; Ruidavets JB; Amouyel P; Ducimetiere P
    Atherosclerosis; 2000 Oct; 152(2):399-405. PubMed ID: 10998468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) concentration does not differ between sexes in healthy offspring of patients with premature myocardial infarction.
    Barra S; Cuomo V; Silvestri N; Materazzi C; Vitagliano G; Capozzi G; Caruso S; Gaeta G; Trevisan M
    J Cardiovasc Med (Hagerstown); 2011 Jul; 12(7):482-6. PubMed ID: 21519277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
    Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
    Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients into four physiologically discrete groups.
    Konerman M; Kulkarni K; Toth PP; Jones SR
    J Clin Lipidol; 2012; 6(4):368-73. PubMed ID: 22836074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator.
    Kido T; Kondo K; Kurata H; Fujiwara Y; Urata T; Itakura H; Yokoyama S
    Lipids Health Dis; 2017 Nov; 16(1):225. PubMed ID: 29187200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study.
    Hopkins PN; Hunt SC; Schreiner PJ; Eckfeldt JH; Borecki IB; Ellison CR; Williams RR; Siegmund KD
    Atherosclerosis; 1998 Dec; 141(2):333-45. PubMed ID: 9862182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.